Request Your Free Playbook Now:

"ATMPs: Your Guide to Selecting the Right Starting Materials"

This playbook explores how CDMOs and therapeutics firms are better managing their sourcing considerations on the way to market.

Advanced therapy medicinal products (ATMPs) are giving very sick patients unprecedented options. In fact, more than 3,500 cell and gene therapies are in development and up to 21 cell therapy launches and 31 gene therapy launches are expected in 2024. However, finding ways to ensure the safety and efficacy of these novel therapies, all while speeding time to market, is critical to deliver on the promise of ATMPs. That starts with sourcing considerations for optimal raw materials and managing regulatory requirements.

How does your company source the raw and cellular starting materials that go into your precision medicines?

Download the playbook to learn how CDMOs and therapeutics firms are better managing their sourcing considerations to set their programs up for success. Topics include:

• How raw materials affect the consistency of your process and product.
• The essential components of a robust GMP framework.
• Strategies to help you find a trusted vendor.
• A vendor evaluation checklist.

Offered Free by: BioPharma Dive's studioID and BioIVT
See All Resources from: BioPharma Dive's studioID and BioIVT